Some weight-loss drugs produce better outcomes than others, a study published Monday in JAMA Internal Medicine found.
Why it matters: The study confirmed that patients on Mounjaro, a drug approved for diabetes treatment, were both more likely to lose weight and saw larger reductions in body weight than patients on Novo Nordisk's Ozempic, which is approved for the same indication.
Starting this fall, most students at Johns Hopkins' medical school will attend tuition-free thanks to a $1 billion donation from billionaire Mike Bloomberg.
Driving the news: The generous gift is intended to address "twin challenges of declining levels of health and education," Bloomberg said in a letter Monday.
Diagnoses of sexually transmitted diseases jumped nearly 24% among seniors ages 65 and older during the pandemic, new data provided first to Axios by FAIR Health shows.
Why it matters: The data points to the need for conversations about the risks of STDs — which can mimic other age-related conditions — with older patients.
Physician burnout rates have dipped below 50% for the first time since the COVID-19 pandemic began, according to survey data from the American Medical Association.
Why it matters: Physicians are leaving the workforce in droves after a tough four years in health care, exacerbating shortages in the health workforce and leaving gaps in patient care.
A proposed rule that would require the nation's most critical industries to more quickly report cyberattacks is raising the ire of the health care industry, which claims the new directives could actually hinder its response in a crisis.
Why it matters: Cyberattacks have sent shockwaves across the health care industry, but regulators and providers don't agree on how to get a handle on the problem.
